Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus (Q36993242)
Jump to navigation
Jump to search
scientific article published on 11 September 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus |
scientific article published on 11 September 2008 |
Statements
1 reference
Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus (English)
1 reference
Joan T Merrill
1 reference
Ellen M Ginzler
1 reference
Richard Furie
1 reference
William Stohl
1 reference
Michael Becker
1 reference
Nilamadhab Mishra
1 reference
Winn Chatham
1 reference
Arthur Weinstein
1 reference
W Joseph McCune
1 reference
John Zhong
1 reference
Wendy Cai
1 reference
William Freimuth
1 reference
Belimumab Study Group
1 reference
11 September 2008
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference